rupiya.io
⠋Loading...
0%
❯ Analyzing price movements...
Samsrita Labs Ltd is a Diagnostics & Research company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Samsrita Labs Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Create a free account to view momentum, moving averages, and delivery signals.
Upgrade to view volatility, drawdown, factor, and risk metrics.
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | ₹1 Cr | ₹1 Cr | ₹2 Cr | |||||
| Expenses | ₹2 Cr | ₹2 Cr | ₹4 Cr | |||||
| Operating Profit | ₹-1 Cr | ₹-1 Cr | ₹-2 Cr | |||||
| OPM % | -45.3% | -194.8% | -128.4% | |||||
| Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | |||||
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | |||||
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | |||||
| Profit Before Tax | ₹-1 Cr | ₹-1 Cr | ₹-2 Cr | |||||
| Tax | ₹-1 Cr | ₹-1 Cr | ₹-2 Cr | |||||
| Net Profit | ₹-1 Cr | ₹-1 Cr | ₹-2 Cr | |||||
| EPS (₹) | -1.3 | -0.9 | -1.7 | |||||
| Dividend Payout % | 0% | 0% | 0% |
Register free to see 5 more years.
| Quarter | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | |||||||
| Expenses | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | |||||||
| Operating Profit | ₹-1 Cr | ₹-1 Cr | ₹-0 Cr | ₹-1 Cr | |||||||
| OPM % | -164.3% | -171.4% | -111.9% | -216.7% | |||||||
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | |||||||
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | |||||||
| Net Profit | ₹-1 Cr | ₹-1 Cr | ₹-0 Cr | ₹-0 Cr | |||||||
| EPS (₹) | -0.5 | -0.4 | -0.3 | -0.3 |
Register free to see 7 more quarters.
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹10 Cr | ₹12 Cr | ₹14 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹-2 Cr | ₹-0 Cr | ₹-2 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹7 Cr | ₹7 Cr | ₹8 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹5 Cr | ₹5 Cr | ₹6 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹19 Cr | ₹23 Cr | ₹26 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹4 Cr | ₹6 Cr | ₹8 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹19 Cr | ₹23 Cr | ₹26 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Register free to see 5 more years.
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| Mar 2018 | ₹-0 Cr | ₹-1 Cr | ₹1 Cr | — |
| Mar 2019 | ₹-3 Cr | ₹-1 Cr | ₹5 Cr | — |
| Mar 2020 | ₹-3 Cr | ₹-2 Cr | ₹4 Cr | — |
| Mar 2021 | ||||
| Mar 2022 | ||||
| Mar 2023 | ||||
| Mar 2024 | ||||
| Mar 2025 |
Register free to see 5 more years.
No dividend history available.
No corporate actions recorded.
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Dr. Agarwals Health Care Ltd | ₹14,010 Cr | 111.6 | 0.00% | -10.59% |
| Fabtech Technologies Ltd | ₹669 Cr | 15.0 | +12.94% | -37.68% |
| Fischer Medical Ventures Ltd | ₹2,284 Cr | 59.2 | 0.00% | -51.94% |
| Inventurus Knowledge Solutions Ltd | ₹26,681 Cr | 37.7 | 0.00% | -3.62% |
| Indegene Ltd | ₹12,256 Cr | 28.0 | +13.94% | +0.28% |
Create a free account to see institutional ownership snapshots.
Create a free account to view recent director and promoter trades.
Create a free account to view recent institutional deal activity.
Create a free account to view analyst estimate summaries.
Create a free account to view ESG risk and governance summaries.
Upgrade to view issuer ratings, instruments, outlooks, and rating history.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.